Expect delays today when inquiring via email or over the phone, we are experiencing an abnormally high volume of phone and email inquiries.
If you are placing an order with us please order online for the fastest order processing.
×
  • phone 1-855-475-7782 | fax 1-855-475-7787
 

global pharmacy plus review
shop secure
 newsletter

Tarceva (Erlotinib) - 150mg, 30 Tabs

Product Details

Non-Small Cell Lung Cancer

TARCEVA monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.



Results from two, multicenter, placebo-controlled, randomized, Phase 3 trials conducted in first-line patients with locally advanced or metastatic NSCLC showed no clinical benefit with the concurrent administration of TARCEVA with platinum-based chemotherapy [carboplatin and paclitaxel or gemcitabine and cisplatin] and its use is not recommended in that setting.



Pancreatic Cancer

TARCEVA in combination with gemcitabine is indicated for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

  • Quanity:30 Tabs
  • Strength: 150mg
Our Generic Price:
$1750.00

Availability: In stock

$1,750.00

There are no products matching the selection.

1,750.00 In stock